Categories: Latest

International Fertility Lubricant Company, Receives Patent For ‘Conceive Plus’ In India

Sasmar, An International Fertility Lubricant Company, Receives Patent For ‘Conceive Plus’ In India

Brussels, May 29, 2017: Sasmar Pharmaceuticals, a multi-national lubricant design, development, and manufacturing company that specializes in the creation of personal lubricants, fertility lubricants, and lubricant-related products, this week excitedly announced the revolutionary product Conceive Plus, a sperm-friendly fertility lubricant for all trying-to-conceive couples, has been awarded patent no. 278692 by the Indian Patent Office.

As a United States FDA-cleared fertility lubricant that is formulated to be isotonic and meet a pH range compatible with human sperm survival and migration, Conceive Plus is a family-trusted personal lubricant that is taking the world by storm today.

Conceive Plus is the only fertility lubricant that contains Calcium and Magnesium ions to support fertility and the process of conception ,” said John-Michael Mancini Founder and Owner of SASMAR.
“Its unique formula helps users increase pleasure while relieving the negative side effects of sexual dryness. We are incredibly excited that this revolutionary product has now been awarded patent protection in India in addition to the other countries it is readily available.”

The unique composition of Conceive Plus has resulted in studies showing that there were greater than 99% viable human sperm after two hours exposure to the product. Additionally, the product increases the likelihood of conception by assisting sperm migration and bonding of sperm to egg.

With the arrival of the Indian patent, Conceive Plus is now ready for entry on the market in India and the company is now seeking distribution partnerships. “Our goal is to have Conceive Plus available in all pharmacies in India, providing access to this product to all couples in the entire country” said Emmanuelle Gibault-Nowak, Business Development Manager.

“Right now, Conceive Plus is being used in hospitals, fertility clinics, or directly by couples that have just made the incredible decision to have a baby,” said Mancini. “This product is commercialized in over 70 countries around the world today, and we are ecstatic to be adding India to the list.”

Conceive Plus does not negatively impact human sperm function or harm human sperm DNA.
For more information on Conceive Plus fertility lubricant, visit: http://www.conceiveplus.com/what-is-conceive-plus

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Dr. Narendranadh Meda Introduces Esaote’s Cutting-Edge O-Scan MRI Machine to Enhance Podiatric (Foot and Ankle) care in Hyderabad

Hyderabad, December 26, 2024: Dr. Narendranadh Meda, one of the city’s leading Vascular, Endovascular &…

16 hours ago

A Breakthrough in India’s Medical Industry: Bangalore Hospitals Introduces the First 640 Slice CT Scan Imaging

Bangalore, December 26, 2024: Bangalore Hospitals, a renowned brand in healthcare innovation and quality, has introduced…

16 hours ago

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

5 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

5 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

7 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

7 days ago